de la Torre Roger A, Bachman Sharon L, Wheeler Andrew A, Bartow Kevin N, Scott J Stephen
Department of General Surgery, University of Missouri--Columbia, Columbia, MO 65211, USA.
Surgery. 2007 Oct;142(4 Suppl):S39-45. doi: 10.1016/j.surg.2007.06.023.
As minimally invasive surgery (MIS) has grown in scope and complexity, new challenges have been introduced along the way, including the need for endoscopic hemostatic techniques. Traditional electrical and mechanical means are still the mainstay, but new technologies for hemostasis continue to emerge. Restricted access to the operative site can limit the use of some tools, and yet multiple chemical hemostats and tamponading agents are used in MIS today. Systemic agents also have been developed and have a role in certain MIS circumstances. These products allow surgeons to continue to approach more difficult procedures using minimally invasive techniques. On the horizon are the newer, even less-invasive approaches of natural orifice endoluminal and transluminal surgery, which will increase the difficulties with reliable hemostat agents and delivery mechanisms.
随着微创手术（MIS）的范围和复杂性不断增加，在此过程中也引入了新的挑战，包括对内窥镜止血技术的需求。传统的电气和机械手段仍然是主要方法，但止血新技术仍在不断涌现。手术部位的受限进入可能会限制某些工具的使用，然而如今多种化学止血剂和填塞剂被用于微创手术中。全身性药物也已得到开发，并在某些微创手术情况下发挥作用。这些产品使外科医生能够继续使用微创技术处理更具难度的手术。未来即将出现更新的、侵入性更小的自然腔道内镜手术和经腔手术方法，这将增加可靠止血剂及其输送机制的难度。
